Drug intelligence / Profile preview

tiluohuayu + yangxuemingmu

Development stage
Unknown
Lead developer
Eye Hospital, China Academy of Chinese Medical Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Tiluohuayu + Yangxuemingmu is a combination therapy consisting of two Traditional Chinese Medicine (TCM) granule formulations developed by the China Academy of Chinese Medical Sciences Eye Hospital. This combination is specifically investigated for the treatment of normal tension glaucoma (NTG). Tiluohuayu is formulated to promote blood circulation and remove blood stasis (unblocking collaterals), while Yangxuemingmu is designed to nourish the blood and improve visual acuity. The therapeutic rationale is based on the TCM principle of addressing both the branch (stasis) and the root (deficiency) of the disease. Clinically, the combination is intended to provide neuroprotection to the retinal ganglion cells and improve hemodynamic parameters in the retrobulbar vessels, thereby slowing the progression of visual field loss in NTG patients.

Other names
Tiluohuayu granules + Yangxuemingmu granulesTLHY + YXMM

Beyond the preview

Go deeper on tiluohuayu + yangxuemingmu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tiluohuayu + yangxuemingmu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call